Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results
PR Newswire Asia
Company maintains priority focus on clinical programs to develop a novel functional cure for hepatitis B viral (HBV) infection and..
Company maintains priority focus on clinical programs to develop a novel functional cure for hepatitis B viral (HBV) infection and..
The Company is working closely with its commercial partners to supply the combination therapy to patients in need
Brii..
Find these reports informative? You can support my one person revolution!